158 related articles for article (PubMed ID: 9543008)
1. Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein.
Brenner C; Pace HC; Garrison PN; Robinson AK; Rosler A; Liu XH; Blackburn GM; Croce CM; Huebner K; Barnes LD
Protein Eng; 1997 Dec; 10(12):1461-3. PubMed ID: 9543008
[TBL] [Abstract][Full Text] [Related]
2. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
Pace HC; Garrison PN; Robinson AK; Barnes LD; Draganescu A; Rösler A; Blackburn GM; Siprashvili Z; Croce CM; Huebner K; Brenner C
Proc Natl Acad Sci U S A; 1998 May; 95(10):5484-9. PubMed ID: 9576908
[TBL] [Abstract][Full Text] [Related]
3. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
4. Expression in Escherichia coli and simple purification of human Fhit protein.
Pawelczyk T; Kowara R; Golebiowski F; Matecki A
Protein Expr Purif; 2000 Apr; 18(3):320-6. PubMed ID: 10733886
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers.
Pace HC; Hodawadekar SC; Draganescu A; Huang J; Bieganowski P; Pekarsky Y; Croce CM; Brenner C
Curr Biol; 2000 Jul 27-Aug 10; 10(15):907-17. PubMed ID: 10959838
[TBL] [Abstract][Full Text] [Related]
6. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
[TBL] [Abstract][Full Text] [Related]
7. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
8. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
[TBL] [Abstract][Full Text] [Related]
9. MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family.
Lima CD; D'Amico KL; Naday I; Rosenbaum G; Westbrook EM; Hendrickson WA
Structure; 1997 Jun; 5(6):763-74. PubMed ID: 9261067
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
11. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
[TBL] [Abstract][Full Text] [Related]
12. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
Shi Y; Zou M; Farid NR; Paterson MC
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):443-8. PubMed ID: 11085938
[TBL] [Abstract][Full Text] [Related]
13. Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans.
Pekarsky Y; Campiglio M; Siprashvili Z; Druck T; Sedkov Y; Tillib S; Draganescu A; Wermuth P; Rothman JH; Huebner K; Buchberg AM; Mazo A; Brenner C; Croce CM
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8744-9. PubMed ID: 9671749
[TBL] [Abstract][Full Text] [Related]
14. Replacement of Fhit in cancer cells suppresses tumorigenicity.
Siprashvili Z; Sozzi G; Barnes LD; McCue P; Robinson AK; Eryomin V; Sard L; Tagliabue E; Greco A; Fusetti L; Schwartz G; Pierotti MA; Croce CM; Huebner K
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13771-6. PubMed ID: 9391102
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit.
Huang K; Arabshahi A; Wei Y; Frey PA
Biochemistry; 2004 Jun; 43(23):7637-42. PubMed ID: 15182206
[TBL] [Abstract][Full Text] [Related]
17. Fluorimetric detection of enzymatic activity associated with the human tumor suppressor Fhit protein.
Asensio AC; Oaknin S; Rotllán P
Biochim Biophys Acta; 1999 Jul; 1432(2):396-400. PubMed ID: 10407161
[TBL] [Abstract][Full Text] [Related]
18. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
19. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]